Status:

RECRUITING

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

Lead Sponsor:

Saluda Medical Pty Ltd

Conditions:

Chronic Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the E...

Eligibility Criteria

Inclusion

  • 1\. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
  • 2\. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.

Exclusion

  • N/A

Key Trial Info

Start Date :

December 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04662905

Start Date

December 15 2020

End Date

January 1 2027

Last Update

May 13 2025

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

ACT Pain Centre

Garran, Australian Capital Territory, Australia, 2605

2

Sydney Pain Specialists

Bella Vista, New South Wales, Australia, 2153

3

Genesis Research Services

Broadmeadow, New South Wales, Australia, 2292

4

Northern Integrated Pain Management

Charlestown, New South Wales, Australia, 2290

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain | DecenTrialz